Latest News and Press Releases
Want to stay updated on the latest news?
-
Enrollment continues to progress in Phase 3 AURORA trial of Descartes-08 in myasthenia gravis Phase 2 TRITON trial of Descartes-08 in dermatomyositis and antisynthetase syndrome initiated Multiple...
-
KT-621 (STAT6) parallel Phase 2b trials, BROADEN2 in atopic dermatitis and BREADTH in asthma, ongoing with data expected by mid-2027 and late 2027, respectively FDA granted Fast Track designation to...
-
ORLANDO, Fla., April 30, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the...
-
CUPERTINO, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- Ambow Education Holding Ltd. ("Ambow" or the "Company") (NYSE American: AMBO), a global innovator of AI-powered phygital (physical + digital)...
-
Med virkning fra den 30. april 2026 offentliggøres nyt prospekt for Investeringsforeningen SparDanmark Invest. Prospektet er opdateret med følgende: Nyt afsnit om likviditetsstyringsværktøjer er...
-
Q1’26 Total Net Revenue of $317 Million, Up 19% YoYQ1’26 Total SUBLOCADE® Net Revenue of $232 Million, Up 32% YoY Q1'26 GAAP Net Income of $89 Million and Q1'26 Non-GAAP Net Income of $123...
-
Rotterdam, The Netherlands (30 April 2026) – IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, announces that all...
-
At one-year mark, company has progressed all components of US investment plan to support delivery of innovative medicines to US patientsNew active pharmaceutical ingredients facility in North Carolina...
-
NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Stanmore...
-
Arcoma AB meddelar idag lanseringen av en ny 3D-kamera med avancerat visuellt positioneringsstöd till företagets röntgensystem Precision i5.